Head-to-head · WeighScore
AskRx vs Levers Health
The verdict
AskRx takes it — 55.8/100 to 53.3/100.
AskRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications for weight loss - no compounded drugs.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AskRx | Levers Health |
|---|---|---|
| WeighScore | 55.8/100 | 53.3/100 |
| Grade | C | C |
| Scorecard rank | #430 | #469 |
| Semaglutide | $349/mo (all doses, brand-name) | $247/mo (1.25 mg dose, compounded) |
| Tirzepatide | $299/mo (2.5 mg dose, brand-name) | $296/mo (5 mg dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #430 · C
Strengths
- Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
- LegitScript approved and HIPAA compliant
- Board-certified physicians trained in obesity medicine
- Transparent dose-based pricing published on site
- Available in all 50 states
Where it loses points
- Cash-pay model; medication cost billed separately by the pharmacy
- Does not dispense medication itself, so fulfillment depends on third-party pharmacies
- No compounded lower-cost alternative offered
- Specific list of supported states is not published
Graded #469 · C
Strengths
- Named LLC entity
- Microdose GLP-1 option marketed for longevity
- Both semaglutide and tirzepatide available
Where it loses points
- No LegitScript or PCAB accreditation
- No physical address disclosed
- State availability not disclosed
- FAQ and terms pages return 404
- Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.